» Articles » PMID: 22662266

Respiratory Syncytial Virus Matrix Protein Induces Lung Epithelial Cell Cycle Arrest Through a P53 Dependent Pathway

Overview
Journal PLoS One
Date 2012 Jun 5
PMID 22662266
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is the major cause of viral respiratory infections in children. Our previous study showed that the RSV infection induced lung epithelial cell cycle arrest, which enhanced virus replication. To address the mechanism of RSV-induced cell cycle arrest, we examined the contribution of RSV-matrix (RSV-M) protein. In this report, we show that in both the A549 cell line and primary human bronchial epithelial (PHBE) cells, transfection with RSV-M protein caused the cells to proliferate at a slower rate than in control cells. The cell cycle analysis showed that RSV-M protein induced G1 phase arrest in A549 cells, and G1 and G2/M phase arrest in PHBE cells. Interestingly, RSV-M expression induced p53 and p21 accumulation and decreased phosphorylation of retinoblastoma protein (Rb). Further, induction of cell cycle arrest by RSV-M was not observed in a p53-deficient epithelial cell line (H1299). However, cell cycle arrest was restored after transfection of p53 cDNA into H1299 cells. Taken together, these results indicate that RSV-M protein regulates lung epithelial cell cycle through a p53-dependent pathway, which enhances RSV replication.

Citing Articles

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity.

Ressel S, Kumar S, Bermudez-Barrientos J, Gordon K, Lane J, Wu J Nucleic Acids Res. 2024; 52(9):4872-4888.

PMID: 38412296 PMC: 11109944. DOI: 10.1093/nar/gkae116.


APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis.

Gladwell W, Yost O, Li H, Bell W, Chen S, Ward J Int J Mol Sci. 2023; 24(23).

PMID: 38069117 PMC: 10706465. DOI: 10.3390/ijms242316793.


Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus.

Attaianese F, Guiducci S, Trapani S, Barbati F, Lodi L, Indolfi G Pathogens. 2023; 12(9).

PMID: 37764926 PMC: 10536346. DOI: 10.3390/pathogens12091118.


Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation.

Kaler J, Hussain A, Patel K, Hernandez T, Ray S Cureus. 2023; 15(3):e36342.

PMID: 37082497 PMC: 10111061. DOI: 10.7759/cureus.36342.


Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?.

Amiama-Roig A, Perez-Martinez L, Rodriguez Ledo P, Verdugo-Sivianes E, Blanco J Microorganisms. 2023; 11(3).

PMID: 36985286 PMC: 10051562. DOI: 10.3390/microorganisms11030713.


References
1.
Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J . Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol. 2002; 83(Pt 4):753-757. DOI: 10.1099/0022-1317-83-4-753. View

2.
Restle A, Janz C, Wiesmuller L . Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination. Oncogene. 2005; 24(27):4380-7. DOI: 10.1038/sj.onc.1208639. View

3.
Shay D, Holman R, Newman R, Liu L, Stout J, Anderson L . Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999; 282(15):1440-6. DOI: 10.1001/jama.282.15.1440. View

4.
Yi F, Saha A, Murakami M, Kumar P, Knight J, Cai Q . Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology. 2009; 388(2):236-47. PMC: 4287381. DOI: 10.1016/j.virol.2009.03.027. View

5.
Casavant N, Luo M, Rosenke K, Winegardner T, Zurawska A, Fortunato E . Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol. 2006; 80(17):8390-401. PMC: 1563868. DOI: 10.1128/JVI.00505-06. View